Dr. Jagadeesh Rao has been our Scientist since October 2017. He leads our product development in the areas of Alzheimer’s disease, Parkinson’s disease, neuroscience, and other neuropsychiatric disorders. He has extensive experience working at various Institutions of the National Institutes of Health (NIH) from 2003 to 2017. Dr. Rao was Scientific Review Officer at the National Institute of Drug Abuse; Previously, he held various positions including Staff Scientist at the NIH. Prior to that Dr. Rao worked on herbal drugs and characterized the biological efficacy of various plant extractions at Himalaya Drug Company. Dr. Rao had worked at Pharmaceutical Research and Development, Johnson & Johnson and involved in characterizing the CNS drugs and efficacy studies.
Dr. Rao received his Ph.D. in Neurochemistry, in 1998, from the National Institute of Mental Health & Neurosciences, India. He did his post-doctoral training at the University of Illinois at Chicago, where he worked on major depression and bipolar disorder projects as well as animal models of depression. Dr. Rao is an elected associate member to the American College of Neuropsychopharmacology.